Buscar
Mostrando ítems 1-10 de 30
Promises and challenges: cabotegravir for preexposure prophylaxis
(Wolters Kluwer, 2022)
Cabotegravir is not associated with weight gain in HIV-uninfected individuals in HPTN 077
(Oxford University Press, 2019)
Promises and challenges: cabotegravir for preexposure prophylaxis
(Wolters Kluwer, 2022)
Tratamiento profiláctico preexposición para VIH-1. Eficacia, seguridad y adherencia. Revisión sistemática
(Universidad de Cuenca, 2022-05-04)
Background: In Ecuador, until 2017, 35,544 people live with HIV, turning it into a concentrated epidemic, which is why a prevention strategy for to avoid seroconversion becomes a public health priority.
Objective: Synthesize ...